Thomas G Wiggans is Chief Executive Officer of PARDES BIOSCIENCES, INC.. Currently has a direct ownership of 0 shares of PRDS, which is worth approximately $0. The most recent transaction as insider was on Aug 31, 2023, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

THOMAS G WIGGANS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 31 2023
SELL
Disposition due to a tender of shares in a change of control transaction
-
50,000 Reduced 100.0%
0 Common Stock
Dec 05 2022
BUY
Open market or private purchase
$13,625 $1.09 p/Share
12,500 Added 20.0%
50,000 Common Stock
Dec 02 2022
BUY
Open market or private purchase
$13,375 $1.07 p/Share
12,500 Added 25.0%
37,500 Common Stock
Dec 01 2022
BUY
Open market or private purchase
$26,000 $1.04 p/Share
25,000 Added 50.0%
25,000 Common Stock

Also insider at

CBAY
CymaBay Therapeutics, Inc. Healthcare
ANNX
Annexon, Inc. Healthcare
FMTX
Forma Therapeutics Holdings, Inc. Healthcare
JSPR
Jasper Therapeutics, Inc. Healthcare
TGW

Thomas G Wiggans

Chief Executive Officer
Carlsbad, CA

Track Institutional and Insider Activities on PRDS

Follow PARDES BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRDS shares.

Notify only if

Insider Trading

Get notified when an Pardes Biosciences, Inc. insider buys or sells PRDS shares.

Notify only if

News

Receive news related to PARDES BIOSCIENCES, INC.

Track Activities on PRDS